Clinical Trial Update: Study of CS-1008 in Patients With Advanced Solid Malignancies and Lymphomas (Without Leukemic Component) [Phase 1]

View source ↗

Summary

A Phase 1 study of CS-1008 in patients with advanced solid malignancies and lymphomas (without leukemic components) has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Lymphoma
• Solid Tumors

Drugs mentioned

• CS-1008

Snippet

Sponsor: Daiichi Sankyo | Conditions: Malignancies, Lymphoma | Phase 1 | Status: COMPLETED